Patientswith breast cancers (n=116, P=0.025) thatexpressed higher mRNA levels of Bcl-3 had a significantly lowermetastasis-free survival than patients whose tumors expressed lower levelsof Bcl-3 (Figure 1c). The gene discussed is BCL3; the disease is breast carcinoma.